We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPFI:NASDAQSouth Plains Financial, Inc. Analysis

Data as of 2026-09-01 - not real-time

$43.60

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

At $43.60, South Plains Financial, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Across the trailing 30 sessions it lost 1.4%. RSI sits at 42.2, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $42.68 and resistance at $46.00.
The shares look undervalued, trading on 11.8 times earnings below a sector average of 16.9. Sell-side targets cluster 16.4% above the current quote. Revenue is growing at 23.0% on a 29.1% profit margin. The 1.65% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 13.9%, a beta of 0.30 and a maximum drawdown of 12.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

Yahoo Finance9monSouth Plains Financial to Buy BOH Holdings in $106 Million All-Stock DealThe above button links to...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 41.64
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.8 versus sector average of 16.9
  • Trading above the 200-day average of 41.64

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 11.8 versus sector average of 16.9
  • Analyst targets imply +16.4% versus the current price
  • Profit margin of 29.1% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth23.00%
Profit Margin29.09%
P/E Ratio11.8
ROE12.02%
ROA1.34%
P/B Ratio1.3
Op. Cash Flow$80.7M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI42.2
Support$42.68
Resistance$46.00
MA 20$44.60
MA 50$43.90
MA 200$41.64
MACDBearish
VolumeStable
Fear & Greed Index94.79

Valuation

Fair Value$135.69
Target Price$50.75
Upside/Downside16.40%
GradeUndervalued
TypeBlend
Dividend Yield1.65%

Risk Assessment

Beta0.30
Volatility13.85%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.